Bovine herpesvirus 1 (BHV-1) glycoprotein glI1 functions both as a major virus attachment protein and haemagglutinating protein. Here we constructed recombinant baculovirus incorporating the BHV-1 gill coding sequence to characterize the expression, function and irnmunogenicity of the glycoprotein in insect cells. The recombinant gill had an M r of 72K and seemed to form homodimers. The gill was expressed on the surface of insect cells and a rosette formation assay demonstrated haemadsorbing activity of the glycoprotein. Antigenic authenticity of the recombinant glII was confirmed by a panel of monoclonal antibodies specific for the glycoprotein produced in mammalian cells. Antisera raised to recombinant glII neutralized the infectivity of BHV-1. These data suggest that recombinant glII produced in insect cells may be a useful immunogen in a BHV-1 vaccine.
Bovine herpesvirus 1 (BHV-1) gIII and the homologous glycoproteins of other herpesviruses, such as herpes simplex virus (HSV) gC (Swain et al., 1985) , pseudorabies virus (PRV) gIII (Robbins et al., 1986) , equine herpesvirus 1 gpl3 (Allen & Coogle, 1988) , varicella-zoster virus gpV (Kinchington et al., 1986 ) and Marek's disease virus A antigen (Binns & Ross, 1989) , have been proposed to be members of an immunoglobulin superfamily. They were therefore presumed to be implicated in the complex host-virus relationships governing the immunology of herpesvirus infection (Fitzpatrick et al., 1990) . BHV-1 gIII (Okazaki et al., 1991) , as well as HSV gC (Herold et al., 1991) and PRV gIII (Mettenleiter et al., 1990) , were also demonstrated to bind to a cell surface heparin-like moiety which is involved in neuronal cell to cell adhesion (Cole et al., 1986) , and the binding of various biological substances such as basic fibroblast growth factor (Shing et al., 1984; Yayon et al., 1991) , fibronectin (Laterra et al., 1983; Yamada et al., 1980) and platelet factor 4 (Laterra et al., 1983) .
BHV-1 gIII is a major viral glycoprotein of approximately 90K and assembles into homodimers. It is located on the virion envelope and on the surface of infected cells (van Drunen Littel-van den Hurk et al., 1984; Marshall et al., 1986; Okazaki et al., 1987) . Expression studies using the SRc~ promoter system showed that gIII bound to C57BL mouse erythrocytes independently of any other viral component and that the binding was inhibited by heparin (Okazaki et al., 1994) . These data suggest that the glycoprotein binds to the cellular receptor independently. Although glII is not an essential protein for virus propagation, it plays a dominant role in virus attachment in cell culture (Liang et al., 1991) , and appears to be responsible for maintaining virus replication efficiency in cattle, the natural host of BHV-1 (Liang et al., 1992) . The glycoprotein is also a major target of immune responses at both the humoral and cellular levels (Babiuk et al., 1987; Fitzpatrick et al., 1990) and is therefore thought to be one of the candidates for a subunit vaccine against BHV-1 infection.
In this study we constructed a recombinant baculovirus to produce BHV-1 glII at high levels. The recombinant gIII expressed in insect cells bound to mouse erythrocytes and was recognized by a panel of monoclonal antibodies (MAbs) against gIII. Furthermore, antibodies raised in rabbits immunized with the recombinant glycoprotein neutralized the infectivity of BHV-1. These findings suggest that the recombinant baculovirus-insect cell system produced biologically active and antigenically authentic glII glycoprotein.
The complete coding sequence of the gene for gIII was excised from the plasmid pTFgIII (Okazaki et al., 1993) by digestion with BamHI, and cloned into the BamHI site of pAcYM1 (Matsuura et al., 1987) under the control of the baculovirus polyhedrin promoter. The resulting plasmid, pAcBHG3, contained 63 BHV-1 nucleotides upstream of the first ATG of the gIII gene, followed by the complete gIII coding sequence and then 0"2 kb nucleotides downstream. Spodoptera frugiperda (Sf-9) cells were cotransfected with pAcBHG3 DNA and • 49K
• 33K Fig. 1 . lmmunoprecipitation assay for the detection of glII. Cells infected with recombinant baculovirus AcBHG3V (lanes 1 to 6) or BHV-1 (lane 7) were lysed with 1% Triton X-100, clarified by centrifugation, incubated with MAbs against gIII and then precxpitated with Protein A-Sepharose. The samples were subjected to SDS PAGE and electroblotted to PVDF membrane (Millipore). After blocking, the membrane was incubated with rabbit hyperimmune serum against BHV-1 and alkaline phosphatase-conjugated anti-rabbit IgG antibodies (Promega . fl-Galactosidase-negative recombinants were isolated by plaque purification as previously described (Summers & Smith, 1987) . Recombinant baculovirus, A c B H G 3 V , was inoculated onto Sf-9 cells at an m.o.i, o f 10 p.f.u./cell and examined for the expression o f gIII. The cells were harvested at 0, 12, 24, 36, 48 and 72 h post-inoculation (p.i.), lysed with 1% Triton X-100, incubated with M A b s against gIII (Okazaki et al., 1986) and then precipitated with Protein A-Sepharose. Samples equivalent to 2 x 105 cells were electroblotted onto P V D F membrane (Millipore) and the antigen was detected by anti-BHV-1 rabbit hyperimmune serum (Fig. 1) . A 72K band, which was absent at 0 h p.i., was detected at 24 h p.i. After 48 h p.i., in addition to the predicted 120K gIII dimers, we observed weak bands comigrating with the authentic gIII. These findings indicate that the major part of gIII expressed in insect cells was smaller than that expressed in mammalian cells. As BHV-1 gIII consists of 521 amino acid residues with a predicted M r o f 55K (Fitzpatrick et al., 1989) , the recombinant gIII m a y be partially glycosylated. Other glycoproteins expressed in insect cells, such as influenza virus haemagglutinin (Kuroda et al., 1990) and BHV-1 gI (van Drunen Littel-van den H u r k et aI., 1992), were shown to contain incomplete carbohydrate side chains. On the other hand, the finding that weak bands of recombinant gIII comigrated with authentic molecules Fig. 2 . Rosette formation by AcBHG3V-infected Sf-9 cells. Cells infected with the recombinant baculovirus (a) or the parental virus AcLacZV (b) were mixed with C57BL mouse erythrocytes at a ratio of 1 to 10 and centrifuged at 100g for 10 min, then incubated for 1 h at 4 °C. The cells were fixed with methanol and immunochemically stained as described in the legend of Fig. 1 . m a y suggest that a small portion of the side chains were fully processed in insect cells. The present findings also suggest that the gIII was dimerized in insect cells. Oligomerization has been shown to be important for transport to the cell surface and for the subsequent functional expression of viral glycoproteins, such as influenza virus haemagglutinin (Copeland et al., 1986) , vesicular stomatitis virus G protein (Krels & Lodish, 1986 ) and HSV-1 g H (Hutchinson et al., 1992) . * AcBHG3V-infected Sf-9 cells of BHV-l-infected MDBK cells were fixed with methanol and acetone (1:1), incubated with serial twofold dilutions of MAbs against BHV-1 glII (Okazaki et al., 1986) , and stained with fluorescein isothiocyanate-conjugated anti-mouse IgG antibodies (Seikagaku). Fluorescent antibody (FA) fitres were expressed as the reciprocals of the maximal dilution of MAbs detecting the antigen. Sf-9 cells < 10 * Japanese white rabbits were immunized three times at 2 week intervals with frozen and thawed whole insect cells expressing gIII or with purified BHV-1 virions. Intramuscular injections were given with 1 x l0 s cells infected with the recombinant baculovirus mixed with Freund's complete adjuvant on days 0 and 14. Intravenous injections were given without adjuvant on day 28. The animals were bled 10 days after the final injection. A neutralization assay was performed in the presence of complement as previously described (Okazaki et aI., 1986) .
Neutralization titre was expressed as the reciprocal of a serum dilution giving a 50 % reduction in plaque number compared with the control, Sf-9 cells infected with AcBHG3V.
To ascertain the functional integrity of recombinant gIII, we examined its ability to bind to C57BL mouse erythrocytes. Cells infected with the recombinant virus AcBHG3V or parental AcLacZV were incubated with the erythrocytes at 72 h p.i., fixed, and then expression of the glycoprotein was visualized by immunostaining with anti-BHV-1 rabbit serum. Fig. 2 clearly shows that cells which were infected with AcBHG3V expressed gIII and adsorbed the erythrocytes. The data also show that gIII synthesized in insect cells was transported to, and embedded in, the plasma membrane. Neither expression of the glycoprotein nor rosette formation was observed on cells infected with AcLacZV.
The antigenic properties of recombinant gIII were assessed using a panel of MAbs specific for BHV-1 gIII produced in mammalian cells. Sf-9 cells and MDBK cells infected with AcBHG3V and BHV-1 respectively were fixed with methanol and acetone (1:1) and their reactivity with the MAbs was examined by indirect immunofluorescence staining as previously described (Okazaki et al., 1987) . As shown in Table 1 , at least three neutralizing antigenic sites as well as one non-neutralizing site were conserved on gIII expressed in insect cells.
The immunogenicity of the gIII was studied using rabbits ( Table 2 ). The animals immunized with AcBHG3V-infected Sf-9 cells produced antibodies against BHV-1 which neutralized the infectivity of the virus, although the titres were lower than those of serum directed against BHV-1. No neutralizing activity was detected in serum from rabbits immunized with uninfected Sf-9 cells.
The gIII was not produced at high enough levels in the recombinant virus-infected insect cells to be discriminated from cellular protein by SDS-PAGE using Coomassie brilliant blue staining (data not shown). 
